103 related articles for article (PubMed ID: 2096922)
1. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Motta-Hennessy C; Eccles SA; Dean C; Coghlan G
Eur J Nucl Med; 1985; 11(6-7):240-5. PubMed ID: 4076230
[TBL] [Abstract][Full Text] [Related]
3. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
4. Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity.
Slinkin MA; Klibanov AL; Torchilin VP
Bioconjug Chem; 1991; 2(5):342-8. PubMed ID: 1790174
[TBL] [Abstract][Full Text] [Related]
5. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
6. Chemically optimized antimyosin Fab conjugates with chelating polymers: importance of the nature of the protein-polymer single site covalent bond for biodistribution and infarction localization.
Trubetskoy VS; Narula J; Khaw BA; Torchilin VP
Bioconjug Chem; 1993; 4(4):251-5. PubMed ID: 8218480
[TBL] [Abstract][Full Text] [Related]
7. [67Ga]desferrioxamine--HSA: synthesis of chelon protein conjugates using carbodiimide as a coupling agent.
Janoki GA; Harwig JF; Chanachai W; Wolf W
Int J Appl Radiat Isot; 1983 Jun; 34(6):871-7. PubMed ID: 6874113
[TBL] [Abstract][Full Text] [Related]
8. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
[TBL] [Abstract][Full Text] [Related]
9. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
Slinkin MA; Curtet C; Faivre-Chauvet A; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
12. An antibody-desferrioxamine conjugate labelled with 67Ga.
Ward MC; Roberts KR; Babich JW; Bukhari MA; Coghlan G; Westwood JH; McCready VR; Ott RJ
Int J Rad Appl Instrum B; 1986; 13(5):505-7. PubMed ID: 3818312
[TBL] [Abstract][Full Text] [Related]
13. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
14. Modification of monoclonal antimyosin antibody: enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction.
Khaw BA; Torchilin VP; Klibanov AL; Nossiff ND; Powers JB; Strauss HW; Haber E
J Mol Cell Cardiol; 1989 Feb; 21 Suppl 1():31-5. PubMed ID: 2733028
[TBL] [Abstract][Full Text] [Related]
15. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
16. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ
Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582
[TBL] [Abstract][Full Text] [Related]
17. The antibody-linked chelating polymers for nuclear therapy and diagnostics.
Torchilin VP; Klibanov AL
Crit Rev Ther Drug Carrier Syst; 1991; 7(4):275-308. PubMed ID: 2040018
[TBL] [Abstract][Full Text] [Related]
18. Thiol-containing cross-linking agent with enhanced steric hindrance.
Greenfield L; Bloch W; Moreland M
Bioconjug Chem; 1990; 1(6):400-10. PubMed ID: 2129154
[TBL] [Abstract][Full Text] [Related]
19. Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma.
Slinkin MA; Curtet C; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
Bioconjug Chem; 1992; 3(6):477-83. PubMed ID: 1463777
[TBL] [Abstract][Full Text] [Related]
20. [The conjugation of preliminarily immunosorbent-immobilized 5B4D6 monoclonal antibodies with a chelating polymer].
Mukhamedova NM; Slinkin MA
Biull Eksp Biol Med; 1992 Dec; 114(12):590-2. PubMed ID: 1292680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
